2002
DOI: 10.1016/s0960-894x(02)00512-7
|View full text |Cite
|
Sign up to set email alerts
|

Identification and Structure–Activity Studies of Novel Ultrashort-Acting Benzodiazepine Receptor Agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 10 publications
0
15
0
Order By: Relevance
“…A set of soft benzodiazepines were developed originally by GlaxoSmithKline on the basis of the remifentanil experience, and were intended as i.v. agent with a predictable fast-onset, short duration of action, and rapid recovery profile [367,368]. They are soft analogs of diazepam (161), bromazepam (162), or midazolam (163), and several ester-containing side chains at the 3-position were explored.…”
Section: Soft Benzodiazepine Analogsmentioning
confidence: 99%
See 1 more Smart Citation
“…A set of soft benzodiazepines were developed originally by GlaxoSmithKline on the basis of the remifentanil experience, and were intended as i.v. agent with a predictable fast-onset, short duration of action, and rapid recovery profile [367,368]. They are soft analogs of diazepam (161), bromazepam (162), or midazolam (163), and several ester-containing side chains at the 3-position were explored.…”
Section: Soft Benzodiazepine Analogsmentioning
confidence: 99%
“…A number of them maintained high binding affinity at the benzodiazepine receptor (<50 nM), showed good (>100-fold) separation of activity between the (active) ester and the (inactive) acid, and were able to cause loss of the righting reflex (LRR) in rats, an effect associated with benzodiazepine full agonism. Structures such as CNS 7259X (164) [367,369] and CNS 7056 (166) [368,370] (Fig. 37) were selected for development, which has been taken over by CeNeS and later PAION.…”
Section: Soft Benzodiazepine Analogsmentioning
confidence: 99%
“…B Gang Liu gangliu27@tsinghua.edu.cn 1 structure, the 1,4-benzodiazepine-2-one (1,4-BZD) scaffold exhibits many kinds of biological activities, such as hypnosis, sedation, and muscle relaxation, [2,3]. Recent investigations [4][5][6][7] indicated that a C3-chiral side chain in 1,4-BZDs is essential for their action on the corresponding biological targets, such as ultra short-acting benzodiazepine receptor agonism [4], BACE-1 inhibition [5], cysteine protease inhibition [6], and antitumor proliferation [7] (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, a Cu-catalyzed selective amidation of aryl [1,4]diazepin-2(3H)-ones halides and amino acid amides was discovered by the Zeng group (note: the selective amidation of aryl halides and amino acid amides via Cu-catalyzation was recently reported by Dong et al [18]. ), and a series of linear aryl-substituted amino acid amides were prepared using Zeng's method.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation